-transparent.png){kind=logo}
The present communication reports the inhibitory action of aminoglutethimide on 9,10-dimethyl-1,2-benzanthracene (DMBA) induced mammary carcinogenesis in virgin female Holtzman rats. When 20 mg of DMBA is given to the rats and maintained on normal diet for 32 weeks, approximately 70% of the animals develop mammary tumors. When animals similarly treated with DMBA are put on diets containing 0.025%, 0.05%, and 0.1% of aminoglutethimide for 32 weeks, there is a decline in the number of tumor-bearing animals as well as in the number of tumors per tumor-bearing animal, especially at higher diet doses of the drug. This inhibitory action on the induction of mammary tumors by DMBA could be mainly due to the suppressive action of the drug on endocrine functions.
A R Rao, and
M G Das, and
P Das
November 1981,
International journal of cancer,
A R Rao, and
M G Das, and
P Das
May 1990,
Indian journal of experimental biology,
A R Rao, and
M G Das, and
P Das
August 1990,
British journal of cancer,
A R Rao, and
M G Das, and
P Das
June 2012,
Carcinogenesis,
A R Rao, and
M G Das, and
P Das
January 1991,
Nutrition and cancer,
A R Rao, and
M G Das, and
P Das
December 1989,
Breast cancer research and treatment,
A R Rao, and
M G Das, and
P Das
January 2012,
Chinese medical journal,
A R Rao, and
M G Das, and
P Das
October 2003,
Indian journal of physiology and pharmacology,
A R Rao, and
M G Das, and
P Das
September 2004,
Carcinogenesis,
A R Rao, and
M G Das, and
P Das
May 2008,
Nutrition (Burbank, Los Angeles County, Calif.),
